T Cell Immunotherapy Show Promising Results For Leukemia

Almost 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a personalized cell therapy that reprograms a patient's immune system. In pilot studies of bio-engineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment - 22 children treated at The Children's Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania. read more

Read the whole article on

More from